The All India Institute of Medical Sciences (AIIMS) is going to start a booster dose trial of Bharat Biotech’s Covid 19 vaccine from this week. As report says, this trial will be conducted on more than 800 participants.
The objective of the trial — titled as ‘Phase 3, Randomized, Multi-Centric, Open-labeled Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose in Participants Previously Vaccinated with EUA Vaccines’ — is to understand the best combination of heterologous boosting.
As expert says this trial study will evaluate the immunogenicity and safety as a booster dose in individuals in india. Post two months of vaccination, an interim report will be notified to the Central Drugs Standard Control Organization (CD
